| Manufacturing Network Grant | Brian Fury | Creating A Collaborative California Cell and Gene Therapy Manufacturing Network |
$1,543,522 |
| Conference – The Alpha Stem Cell Clinic Annual Symposium | Dr Mehrdad Abedi | CIRM – Leading the New Era of Living Medicines |
$6,738 |
| Alpha Stem Cell Clinics Network Expansion | Dr Mehrdad Abedi | Alpha Stem Cell Clinic for Northern and Central California |
$7,999,997 |
| Alpha Stem Cell Clinics Network Expansion | Dr Mehrdad Abedi | Alpha Stem Cell Clinic for Northern and Central California |
$8,076,421 |
| Conference – Manage The SPARK Annual Meeting | Gerhard Gerhard Bauer | The 2020 SPARK Annual Meeting |
$22,876 |
| Conference – Manage The SPARK Annual Meeting | Gerhard Gerhard Bauer | The 2018 SPARK Annual Meeting |
$39,391 |
| Quest – Discovery Stage Research Projects | Ricardo Anibal Maselli MD | Treatment of Myasthenic Syndrome due to Choline Acetyltransferase Deficiency Using AAV9-mediated Gene Therapy |
$1,500,000 |
| Quest – Discovery Stage Research Projects | Aijun Wang PhD | In Utero Treatment of Duchenne Muscular Dystrophy with Non-viral Gene Editing |
$2,035,544 |
| Quest – Discovery Stage Research Projects | Dr. Kyle D Fink PhD | AAV-dCas9 Epigenetic Editing for CDKL5 Deficiency Disorder |
$1,429,378 |
| Quest – Discovery Stage Research Projects | Dr. David J Segal PhD | AAV9-Cas13 gene therapy for Angelman syndrome |
$1,364,903 |
| Quest – Discovery Stage Research Projects | Dr. Deborah K Lieu | Building a hiPSC-based biopacemaker |
$1,260,827 |
| Quest – Discovery Stage Research Projects | Dr. Deborah K Lieu | Microenvironment for hiPSC-derived pacemaking cardiomyocytes |
$2,042,438 |
| Quest – Discovery Stage Research Projects | Dr. David J Segal PhD | MSC delivery of an artificial transcription factor to the brain as a treatment for Angelman Syndrome |
$1,055,319 |
| Inception – Discovery Stage Research Projects | Dr. Alice F Tarantal | Enhanced Branching Morphogenesis and Pluripotent Cell Lineage Differentiation for Pediatric Regenerative Therapies |
$235,800 |
| Inception – Discovery Stage Research Projects | Alyssa Panitch PhD | Development of treatments to improve healing of ischemic wounds |
$235,099 |
| Tool Translational Research Projects | Dr Jan A Nolta | T-Pure: Peripheral Blood Processing Tool for Point of Care CAR-T Manufacturing |
$1,217,954 |
| Medical Device Translational Research Projects | Aijun Wang PhD | Living Synthetic Vascular Grafts with Renewable Endothelium |
$3,082,579 |
| Therapeutic Translational Research Projects | Dr. William J Murphy | Overcoming resistance to standard CD19-targeted CAR T using a novel triple antigen targeted vector |
$3,869,061 |
| Therapeutic Translational Research Projects | Dr. William J Murphy | Placental Derived Natural Killer Cells to Target Solid Tumor Cancer Stem Cells (CSC) |
$0 |
| Therapeutic Translational Research Projects | Dr. Joseph S Anderson | Overexpression of HexA/HexB by lentivector expression in blood cells to treat Tay-Sachs and Sandhoff disease |
$883,174 |
| SPARK | Dr. Fernando A Fierro PhD | Internship at a Cutting Edge CIRM-funded Stem Cell Research Facility |
$499,573 |
| SPARK | Gerhard Gerhard Bauer | Internship at a Cutting Edge CIRM-funded Stem Cell Research Facility |
$360,573 |
| Clinical Trial Stage Projects | Dr. Diana L. Farmer | The CuRe Trial: Cellular Therapy for In Utero Repair of Myelomeningocele |
$8,996,477 |
| Clinical Trial Stage Projects | Peter C Belafsky | A Double-Blind Randomized Placebo-Controlled Investigation of Autologous Muscle Derived Progenitor Cells for the Treatment of Dysphagia |
$11,015,936 |
| Clinical Trial Stage Projects | Dr. Diana L. Farmer | The CuRe Trial: Cellular Therapy for In Utero Myelomeningocele Repair |
$8,905,054 |
| Clinical Trial Stage Projects | Dr Mehrdad Abedi | Stem Cell Gene Therapy for HIV Mediated by Lentivector Transduced, Pre-selected CD34+ Cells in AIDS lymphoma patients |
$8,414,265 |
| Late Stage Preclinical Projects | Dr. Joseph S Anderson | Expression of Ube3a by the hematopoietic system for the treatment of Angelman syndrome |
$4,487,656 |
| Late Stage Preclinical Projects | Dr Mehrdad Abedi | Superior forward-oriented b-globin vector for treating Sickle Cell Disease |
$4,598,398 |
| Late Stage Preclinical Projects | Dr. Joseph S Anderson | Hematopoetic stem cell gene therapy for the treatment of Tay-Sachs disease |
$4,048,253 |
| Late Stage Preclinical Projects | Dr. Diana L. Farmer | Placental Mesenchymal Stem Cell Augmentation of Fetal Myelomeningocele Repair |
$5,615,207 |
| Preclinical Development Awards | Dr. Roslyn Rivkah Isseroff | Scaffold for dermal regeneration containing pre-conditioned mesenchymal stem cells to heal chronic diabetic wounds |
$4,620,144 |
| Preclinical Development Awards | Dr. Diana L. Farmer | Placental Stem Cells for the In Utero Treatment of Spina Bifida |
$2,182,146 |
| Tools and Technologies III | Dr. J. Kent Leach | Multi-modal technology for non-destructive characterization of bioengineered tissues |
$1,574,151 |
| Tools and Technologies III | Dr. Laura Marcu | Multimodal platform combining optical and ultrasonic technologies for in vivo nondestructive evaluation of engineered vascular tissue constructs |
$1,834,350 |
| Conference | Randi Hagerman | Pathways of Neurodevelopmental Disorders (C8) |
$29,939 |
| Conference | Dr. Alice F Tarantal | 13th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases |
$10,000 |
| Conference | Dr. Alice F Tarantal | 10th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases |
$18,300 |
| Conference | Dr. Alice F Tarantal | 9th Annual Gene Therapy Symposium for Heart, Lung and Blood Diseases |
$12,000 |
| Conference | Dr. Alice F Tarantal | 11th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases |
$16,850 |
| Conference | Dr. Mark Yarborough PhD | Stem Cell Research for Neurological Disorders: A Case Study in Ethical and Policy Issues in ALS Research |
$1,020 |
| Conference | Dr. Alice F Tarantal | 12th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases |
$8,000 |
| Major Facilities | Dr. Larry N. Vanderhoef | UC Davis CIRM Institute |
$20,082,400 |
| Disease Team Therapy Development III | Dr. Peter C. Belafsky | Tissue Engineered Recellularized Laryngotracheal Implants |
$3,181,162 |
| Patent Assistance Fund Awards | David McGee | CIRM Patent Prosecution Assistance Fund for Stem Cell Technologies – UCD |
$48,595 |
| New Faculty Physician Scientist | Emanual Michael Maverakis | Tunable hydrogels for therapeutic delivery of multipotent stem cells. |
$2,771,903 |
| Creativity Awards | Gerhard Gerhard Bauer | Internship at a Cutting Edge CIRM-funded Stem Cell Research Facility |
$250,064 |
| Basic Biology IV | Dr. Deborah K Lieu | Induction of Pluripotent Stem Cell-Derived Pacemaking Cells |
$1,333,689 |
| Disease Team Therapy Development – Research | Dr. John Laird | Phase I study of IM Injection of VEGF-Producing MSC for the Treatment of Critical Limb Ischemia |
$3,728,384 |
| Disease Team Therapy Development – Research | Dr. Vicki Wheelock | MSC engineered to produce BDNF for the treatment of Huntington’s disease |
$8,924,235 |
| Disease Team Therapy Development – Research | Nancy E. Lane | Treatment of non-traumatic osteonecrosis with endogenous Mesenchymal stem cells |
$18,227,898 |
| Early Translational III | Walter Douglas Boyd | Extracellular Matrix Bioscaffold Augmented with Human Stem Cells for Cardiovascular Repair |
$4,631,754 |
| Early Translational III | Prof. Kyriacos A. Athanasiou Ph.D | Tissue engineered cartilage from autologous, dermis-isolated, adult, stem (DIAS) cells |
$1,735,703 |
| Training Grant I-1 | Dr. Frederick J Meyers MD | Stem Cell Research Training Grant |
$1,780,859 |
| Disease Team Therapy Planning I | Dr Mehrdad Abedi | Stem Cell Gene Therapy for HIV in AIDS Lymphoma Patients |
$66,880 |
| Disease Team Therapy Planning I | Dr. John Laird | Phase I study of IM Injection of VEGF Producing MSC for the Treatment of Critical Limb Ischemia |
$76,066 |
| Disease Team Therapy Planning I | Dr. Vicki Wheelock | MSC engineered to produce BDNF for the treatment of Huntington’s disease |
$97,564 |
| Disease Team Therapy Planning I | Nancy E. Lane | Increasing the endogenous mesenchymal stem cells to the bone surface to treat osteoporosis |
$107,750 |
| Disease Team Therapy Planning I | Dr. Martin Birchall | Airways for Children |
$19,800 |
| Research Training II | Dr. Frederick J Meyers MD | UC Davis Stem Cell Training Program |
$4,838,291 |
| Early Translational II | Dr. Mark Zern | Liver Cell Transplantation |
$4,212,621 |
| Early Translational II | Dr. Roslyn Rivkah Isseroff | Bone Marrow Mesenchymal Stem Cells to Heal Chronic Diabetic Wounds |
$4,629,747 |
| New Faculty I | Dr. Chong-Xian Pan | Combinatorial Chemistry Approaches to Develop LIgands against Leukemia Stem Cells |
$2,386,409 |
| Early Translational I | Dr. Alice F Tarantal | In Utero Model to Assess the Fate of Transplanted Human Cells for Translational Research and Pediatric Therapies |
$3,143,392 |
| Early Translational I | Dr. Jan Aileen Nolta PhD | Sustained siRNA production from human MSC to treat Huntingtons Disease and other neurodegenerative disorders |
$2,615,674 |
| Transplantation Immunology | Dr. William J Murphy | Donor natural killer (NK) cells as “veto” cells to promote donor-specific tolerance |
$1,257,601 |
| Tools and Technologies I | Kit S Lam | Discovery of adhesion ligands for pluripotent human stem cells |
$834,003 |
| Tools and Technologies I | Dr. Alice F Tarantal | In Vivo Imaging for the Detection and Quantitation of Transplanted Stem/Progenitor Cells in Nonhuman Primates |
$799,350 |
| Shared Labs | Dr. Alice F Tarantal | UC Davis Translational Human Embryonic Stem Cell Shared Research Facility |
$2,000,000 |
| Shared Labs | Dr. Alice F Tarantal | UC Davis Translational Human Embryonic Stem Cell Shared Research Facility |
$1,728,111 |
| New Faculty II | Dr. Paul S. Knoepfler | Molecular mechanisms governing hESC and iPS cell self-renewal and pluripotency |
$2,157,255 |
| Comprehensive Grant | Dr. Mark Zern | An in vitro and in vivo comparison among three different human hepatic stem cell populations. |
$2,251,223 |
| Comprehensive Grant | Dr. Alice F Tarantal | Preclinical Model for Labeling, Transplant, and In Vivo Imaging of Differentiated Human Embryonic Stem Cells |
$2,166,757 |
| SEED Grant | Dr. Ebenezer N Yamoah | Hair Cells and Spiral Ganglion Neuron Differentiation from Human Embryonic Stem Cells |
$458,071 |
| SEED Grant | Professor A. Hari Reddi | hESCs for Articular Cartilage Regeneration |
$301,703 |
| Basic Biology II | Dr. Eric A Kurzrock | Differentiation of Human Embryonic Stem Cells into Urothelium |
$849,037 |
| Basic Biology I | Dr. Min Zhao | Directing migration of human stem cells with electric fields |
$816,228 |
| COMPASS Training Grant | Dr. Alice F Tarantal | COMPASS Undergraduate Program |
$2,909,950 |
| Research Training Grant | Dr Jan A Nolta | CIRM Cell and Gene Therapy Training Program 2.0 |
$5,331,340 |
